ITI Life Sciences, Scotland’s publicly funded innovation group, is to invest a further £2 million in its programme to develop new drug discovery tools.
Thomas Geelhaar, Head of Chemicals R&D at Merck in Darmstadt, Germany, describes how the company scouts for technologies and interacts with universities.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.